Divi's Laboratories Limited

NSE:DIVISLAB.NS

Sector

🧪 Materials

Industries

🔬 Chemicals & Advanced Materials

💊 Pharmaceuticals

Location

India

Market Cap

USD 18.56 B

Share Price

USD 67.43

Avg Daily Volume

443,398

Change (1 day)

-3.83%

Change (1 year)

17.14%

Change (YTD)

-5.36%

Divi's Laboratories Limited EBITDA Margin for the year ending March 31, 2024: 32.42%

Divi's Laboratories Limited EBITDA Margin is 32.42% for the year ending March 31, 2024, a -7.44% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Divi's Laboratories Limited EBITDA Margin for the year ending March 31, 2023 was 35.02%, a -22.90% change year over year.
Divi's Laboratories Limited EBITDA Margin for the year ending March 31, 2022 was 45.42%, a 6.55% change year over year.
Divi's Laboratories Limited EBITDA Margin for the year ending March 31, 2021 was 42.63%, a 12.06% change year over year.
Divi's Laboratories Limited EBITDA Margin for the year ending March 31, 2020 was 38.04%, a -9.36% change year over year.